In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Vivo's Deals Of The Century: A Timeline

Executive Summary

When it comes to deal-making, In Vivo's editors have always been quick to single out transactions that we feel will spark trends or otherwise have a major impact on the life sciences industry. Below, an expandable timeline of the deals we chose as bellwethers for pharma and medtech in each year of this still-young century and what we said about them at the time. (Free article.)

Source Material From In Vivo's Archives

Date

Article

Sept. 2001

Inside Applera: Celera Genomics Becomes Applied Bio's Diagnostics Angel

Oct. 2001

Bristol's Billion-Dollar Ante To Stay In The Cancer Game

Oct. 2002

Vulnerable Plaque Heats Up

Feb. 2004

Jumpstart To Products

Jan. 2005

Elephant Cha-Cha: The J&J/Guidant Deal

June 2006

The Large Molecule Future

Dec. 2006

How To Fix A Guidant: Boston Scientific's Tobin Opens Playbook

Mar. 2007

Proteus Biomedical: Using Computers To Manage Chronic Diseases

May 2007

Kyphon Steps Up

June 2008

Royalty Flush: Why Monetizing Tomorrow's Revenue Stream Today Could Catch On In A Big Way

Oct. 2008

Medtronic Strengthens Hand In Ablation Market With CryoCath Acquisition

Jan. 2010

Pay-for-Performance In The US: What Could Work, What Won't

Dec. 2010

As Pfizer And UCSF Tighten Ties, More Deals With Academia Could Follow

July 2011

Private Bid For KCI Signals Growth In Wound Care

Oct. 2011

iRhythm: Reinventing Arrhythmia Monitoring

Oct. 2012

Could Medtronic’s Kanghui Purchase Set Course For US Entry?

Nov. 2012

A New Industry-Academic Model: Novartis And Penn Make A Splash In Cancer Immunotherapy

Jul. 2014

When Illumina Buys Roche: The Dawning Of The Era Of Diagnostics Dominance

Oct. 2014

GSK’s Venture Deal With Avalon Yields Three Start-Ups In Two Years

Sept. 2015

In Buzz Of 2015 Pharma Dealmaking, Immuno-Oncology Is Queen Bee

Jan. 2016

Value-Based Medtech Rides The Money-Go-Round Into 2016

Dec. 2016

In Vivo's Deals Of The Year 2016

Advertisement

Related Content

Gilead Makes Cell Therapy The Base Of Its Oncology Platform With Kite Buy
BD, CR Bard Merger To Create Vascular Access Device Giant

Topics

Advertisement
UsernamePublicRestriction

Register

IV005182

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel